Printer Friendly

Pharmaceutical and cosmetic foam.

* U.S. Patent No. 7,820,145 B2; Foamix Ltd. has been awarded a U.S. patent for an oleaginous pharmaceutical and cosmetic foam. The foamable therapeutic composition is comprised of 70-96.5% of a solvent phase that contains a hydrophobic solvent, a silicone oil or a mixture thereof and optionally, an emollient, a co-solvent, or a mixture thereof; a nonionic surfactant; a gelling agent; a therapeutically effective amount of at least one active agent; and at least one liquefied or compressed gas pro-pellant. The composition forms a breakable foam upon dispensing that collapses upon application of shear force. The specific gravity of the foam is less than 0.5 g/mL and the water content of the composition is less than approximately 30% by weight.
COPYRIGHT 2010 Rodman Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Patent Review
Publication:Household & Personal Products Industry
Date:Dec 1, 2010
Previous Article:Anti-inflammatory properties of reduced iso-alpha acids.
Next Article:Hair treatment composition.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |